These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 195902)

  • 1. Development of cell-mediated immunity to Epstein-Barr herpesvirus in infectious mononucleosis as shown by leukocyte migration inhibition.
    Lai PK; Alpers MP; MacKay-Scollay EM
    Infect Immun; 1977 Jul; 17(1):28-35. PubMed ID: 195902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell mediated immunity during infectious mononucleosis to Epstein-Barr virus associated antigens.
    Periman P; Levine PH; Ablashi DV; Royston I
    Int J Cancer; 1977 Oct; 20(4):506-11. PubMed ID: 199544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective study on infectious mononucleosis in childhood--symptoms, serology, Epstein-Barr-Virus specific leukocyte migration inhibition.
    Timár L; Budai J; Koller M
    Infection; 1982; 10(3):139-43. PubMed ID: 6286500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abrogation of cell-mediated immunity by a serum blocking factor isolated from patients with infectious mononucleosis.
    Wainwright WH; Veltri RW; Sprinkle PM
    J Infect Dis; 1979 Jul; 140(1):22-32. PubMed ID: 88489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-mediated immunity to Epstein-Barr virus and a blocking factor in patients with infectious mononucleosis.
    Lai PK; Mackay-Scollay EM; Fimmel PJ; Alpers MP; Keast D
    Nature; 1974 Dec; 252(5484):608-10. PubMed ID: 4372559
    [No Abstract]   [Full Text] [Related]  

  • 6. Leukocyte migration inhibition with Epstein-Barr virus negative and positive cell extracts.
    Szigeti R; Timár L; Révész T
    Allergy; 1980 Mar; 35(2):97-103. PubMed ID: 6155797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus (EBV) antigen-specific leukocyte migration inhibition in infectious mononucleosis. II. Kinetics of sensitization against five EBV-encoded nuclear proteins and the latent membrane protein.
    Szigeti R; Kallin B; Dillner J; Henle G; Henle W; Lerner RA; Rymo L; Timar L; Klein G
    Clin Immunol Immunopathol; 1989 Jun; 51(3):396-405. PubMed ID: 2470542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus (EBV) antigen-specific leukocyte migration inhibition (LMI) in infectious mononucleosis (IM). I. Kinetics and response to a membrane protein on EBV-transformed cells.
    Szigeti R; Timar L; Weiland O; Henle W; Henle G; Hennessy K; Kieff E; Sulitzeanu D; Dillner J; Klein G
    Clin Immunol Immunopathol; 1986 Dec; 41(3):342-50. PubMed ID: 3022972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus-specific serum immunoglobulin A as an acute-phase antibody in infectious mononucleosis.
    Nikoskelainen J; Neel EU; Stevens DA
    J Clin Microbiol; 1979 Jul; 10(1):75-9. PubMed ID: 227922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukocyte migration inhibition detects cross-reacting antigens between cells transformed by Epstein-Barr virus (EBV) and EBV-like simian viruses.
    Szigeti R; Rabin H; Timar L; Klein G
    Intervirology; 1986; 26(3):121-8. PubMed ID: 3034820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of different Epstein-Barr virus-determined antigens (EBNA, EA, and VCA) on the leukocyte migration of healthy donors and patients with infectious mononucleosis and certain immunodeficiencies.
    Szigeti R; Masucci MG; Henle W; Henle G; Purtilo D; Klein G
    Clin Immunol Immunopathol; 1982 Jan; 22(1):128-38. PubMed ID: 6288294
    [No Abstract]   [Full Text] [Related]  

  • 12. Epstein-Barr virus infections in childhood.
    Oberender H; Graessner U; Falkenhagen U; Kunkel M; Gärtner L; Kupatz H; Schumacher K
    Acta Virol; 1979 Mar; 23(2):137-42. PubMed ID: 39436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of viral capsid anti-antigen antibodies of the Epstein Barr virus in infectious mononucleosis. Comparative evaluation of a fluorescence method with classic methods].
    Picerno G; Lari M; Fregoso F; Musmanno G
    Quad Sclavo Diagn; 1983 Dec; 19(4):489-98. PubMed ID: 6330785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Leukocyte migration inhibition elicited by Epstein-Barr virus antigen. Reaction potential in infectious mononucleosis as well as in states of immune deficiency and immunosuppression].
    Szigeti R; Klein E; Masucci MG; Ernberg I; Masucci G; Svedmyr E; Klein G
    Orv Hetil; 1982 May; 123(20):1217-21. PubMed ID: 6287380
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationship of in vitro immune responses to Epstein-Barr herpesvirus and severity of infectious mononucleosis.
    Goldstein K; Lai PK; Lightfoote M; Andrese AP; Fuccillo D; Connor RJ; Levine PH
    Infect Immun; 1980 Sep; 29(3):945-52. PubMed ID: 6253402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein Barr virus-specific immune defects in patients with persistent symptoms following infectious mononucleosis.
    Borysiewicz LK; Haworth SJ; Cohen J; Mundin J; Rickinson A; Sissons JG
    Q J Med; 1986 Feb; 58(226):111-21. PubMed ID: 3012622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus nuclear antigen (EBNA)-positive cells in a lymph-node of a child with severe primary EBV infection.
    Lenoir G; De-The G; Virelizier JL; Griscelli C
    IARC Sci Publ (1971); 1978; (24 Pt 2):733-8. PubMed ID: 221396
    [No Abstract]   [Full Text] [Related]  

  • 18. IgM antibodies to Epstein-Barr virus-associated membrane antigen in sera of infectious mononucleosis patients.
    Harada M; Sairenji T; Takaki K; Hinuma Y
    Microbiol Immunol; 1980; 24(2):123-32. PubMed ID: 6247623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Epstein-Barr Virus Load and Genomic Diversity Are Associated with Generation of gp350-Specific Neutralizing Antibodies following Acute Infectious Mononucleosis.
    Weiss ER; Alter G; Ogembo JG; Henderson JL; Tabak B; Bakiş Y; Somasundaran M; Garber M; Selin L; Luzuriaga K
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27733645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.
    Nystad TW; Myrmel H
    J Clin Virol; 2007 Apr; 38(4):292-7. PubMed ID: 17336144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.